Advertisement
Studies show that smoking causes smokers to metabolize caffeine faster.(2)As a result, smokers need to ingest more caffeine to get the same effects ofnonsmokers.(2) So when a smoker tries to quit, they may end up with morecaffeine in their system, and may need to reduce their caffeine intake whentrying to quit. In fact, the survey shows that fewer than one in ten smokers(9 percent) know how smoking affects the way their body processes caffeine.(1)Additionally, about one-third of smokers (about 32 percent) do not know thattoo much caffeine in the blood can be harmful.(1)
Advertisement
According to the survey, almost three quarters (71 percent) of smokersenjoy the flavor of coffee.(1) With the introduction of Commit's cappuccino-flavored lozenge, smokers now have a new flavor of lozenge to conquer theiraddiction to cigarettes. Like other Commit flavors, Commit Cappuccinoprovides low, safe doses of therapeutic nicotine to calm withdrawal symptomsin a new, smooth, coffee flavor.(3) The Commit Cappuccino lozenge helpssmokers quit successfully by calming nicotine cravings, as well as soothingother withdrawal symptoms such as anxiety and irritability, allowing smokersto wean off nicotine gradually and safely.(4)
"It is important smokers understand that they don't need to give up coffeewhen trying to quit, but by drinking less coffee, they may help their bodyadjust to life without cigarettes, and avoid caffeine side effects," said SaulShiffman, PhD, researcher and professor in the departments of psychology andpharmaceutical science at the University of Pittsburgh and GlaxoSmithKlineConsumer Healthcare spokesperson. "The tie between smoking and coffee-drinking is clear and the new Commit Cappuccino lozenge is a great option tohelp a smoker quit in a safe, effective way. It calms nicotine cravings andwithdrawal symptoms, while giving smokers the coffee flavor they enjoy withoutthe caffeine."
The recent 2008 PHS Smoking Cessation Guideline identified the Commitnicotine lozenge as a first-line treatment that can reliably increase long-term smoking abstinence.(5) The Commit lozenge is approved by the U.S. Foodand Drug Administration (FDA) to help relieve withdrawal symptoms and cravingsassociated with quitting smoking and uses a unique dosage selector so thatsmokers can choose the strength that's right for them.(5) For moreinformation, smokers can visit Commitlozenge.com. Visitors can also request afree 24-count of Commit Cappuccino to get their quit attempt started.
About the Commit Lozenge
Commit Cappuccino joins three other lozenge offerings -- Original, Mintand Cherry -- in the Commit family, giving smokers another effectivetherapeutic nicotine option for smoking cessation. Commit is approved by theFDA to help control craving associated with quitting smoking. Commit has aunique dosage selector based on how soon smokers smoke their first cigarettein the morning, so they can choose the strength that's right for them. Commitcomes in different strengths -- 2 mg or 4 mg -- to be used depending on howsoon a smoker has his first cigarette in the morning. The 2 mg dosage is forsmokers who usually have their first cigarette more than thirty minutes afterwaking up. The 4 mg dosage is for smokers who usually have their firstcigarette within thirty minutes of waking up. The Commit lozenge helps peoplestop smoking by providing low, safe doses of therapeutic nicotine to easewithdrawal from cigarettes.
About the Survey
Richard Day Research conducted the Internet survey including 1,095 U.S.adults, including 322 smokers, age 18 and older, selected to reflect the adultU.S. population. The survey was fielded in July 2008 through an online panel.The survey was conducted on behalf of GlaxoSmithKline Consumer Healthcare, theindustry leader in smoking cessation.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline (GSK) Consumer Healthcare is one of the world's largestover-the-counter consumer healthcare products companies. GSK offers thewidest range of proven TN products available, products which can significantlyimprove a smoker's chance of quitting successfully and have helped millions ofpeople quit smoking. In addition, GSK offers several resources and supportservices designed specifically to help smokers and nonsmokers understand andaddress the two components to smoking cessation: nicotine addiction and habitchange. Its more than 30 well-known brands include the leading smokingcessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as well as manymedicine cabinet staples, including Abreva(R), alli(R), Aquafresh(R),Sensodyne(R), Tums(R) and Breathe Right(R), trademarks owned and/or licensedto GlaxoSmithKline Group of Companies.
About GlaxoSmithKline
GlaxoSmithKline is one of the world's leading research-basedpharmaceutical and consumer healthcare companies. GlaxoSmithKline iscommitted to improving the quality of human life by enabling people to domore, feel better and live longer.Other Survey Findings: -- Among the adults surveyed, smokers drink an average of 2.8 cups of coffee per day, while nonsmokers drink 1.5 cups.(1) -- Almost half (about 43 percent) of smokers report that drinking coffee makes them want to have a cigarette.(1)
SOURCE GlaxoSmithKline (GSK) Consumer Healthcare
